skip to main content

Post-ACS antiplatelet therapy — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsPost-ACS antiplatelet therapyGPhC CRA

A discharge prescription for a patient after NSTEMI includes aspirin 75 mg daily and ticagrelor 90 mg twice daily. The patient asks why two antiplatelets are needed. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — The combination reduces further clotting risk after ACS but increases bleeding risk

Dual antiplatelet therapy is commonly used after ACS to reduce further thrombotic events. It also increases bleeding risk, so counselling about bleeding symptoms and adherence is important. It is not a rate-control or gastroprotective treatment.

Reference: BNF; NICE CKS